The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
RAS/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression
Abstract
Mitogen‐activated protein kinase (MAPK) signaling pathways organize a great constitution network that regulates several physiological processes, like cell growth, differentiation, and apoptotic cell death. Due to the crucial importance of this signaling pathway, dysregulation of the MAPK signaling cascades is involved in the pathogenesis of various human cancer types. Oxidative stress and DNA damage are two important factors which in common lead to carcinogenesis through dysregulation of this signaling pathway. Reactive oxygen species (ROS) are a common subproduct of oxidative energy metabolism and are considered to be a significant physiological modulator of several intracellular signaling pathways including the MAPK pathway. Studies demonstrated that the MAP kinases extracellular signal‐regulated kinase (ERK) 1/2 and p38 were activated in response to oxidative stress. In addition, DNA damage is a partly common circumstance in cell life and may result in mutation, cancer, and even cell death. Recently, accumulating evidence illustrated that the MEK/ERK pathway is associated with the suitable performance of cellular DNA damage response (DDR), the main pathway of tumor suppression. During DDR, the MEK/ERK pathway is regularly activated, which contributes to the appropriate activation of DDR checkpoints to inhibit cell division. Therefore, the aim of this review is to comprehensively discuss the critical function of MAPK signaling in oxidative stress, DNA damage, and cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wilhelm, S. M., Carter, C., Tang, L., Wilkie, D., McNabola, A., Rong, H., Chen, C., Zhang, X., Vincent, P., McHugh, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1443 · Cited by 4,017
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
Roberts, P. J., & Der, C. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210422 · Cited by 2,788
Pathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
Mitogenic Signaling Mediated by Oxidants in Ras-Transformed Fibroblasts
Irani, K., Xia, Y., Zweier, J. L., Sollott, S. J., Der, C. J., Fearon, E. R., Sundaresan, M., Finkel, T., & Goldschmidt-Clermont, P. J. (1997) · Science · doi:10.1126/science.275.5306.1649 · Cited by 1,588
Nuclear localization of EGF receptor and its potential new role as a transcription factor
Lin, S.-Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K. Y., Bourguignon, L., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-802 · Cited by 1,064
Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
Santarpia, L., Lippman, S. M., & El-Naggar, A. K. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.645805 · Cited by 1,027
H2AX: the histone guardian of the genome
Fernandez-Capetillo, O., Lee, A., Nussenzweig, M., & Nussenzweig, A. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.024 · Cited by 1,010
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
Sebolt-Leopold, J. S., Dudley, D. T., Herrera, R., Becelaere, K. V., Wiland, A., Gowan, R. C., Tecle, H., Barrett, S. D., Bridges, A., Przybranowski, S., et al. (1999) · Nature Medicine · doi:10.1038/10533 · Cited by 970
ATR disruption leads to chromosomal fragmentation and early embryonic lethality
Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951
The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy
Scaltriti, M., & Baselga, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1554 · Cited by 913
An essential role for free radicals and derived species in signal transduction
Lander, H. M. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.2.9039953 · Cited by 902
Blocking Oncogenic Ras Signaling for Cancer Therapy
Adjei, A. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1062 · Cited by 831
Phosphatase‐mediated crosstalk between MAPK signaling pathways in the regulation of cell survival
Junttila, M. R., Li, S., & Westermarck, J. (2008) · The FASEB Journal · doi:10.1096/fj.06-7859rev · Cited by 826
Reactive Oxygen Species-Induced Activation of the MAP Kinase Signaling Pathways
McCubrey, J. A., LaHair, M. M., & Franklin, R. A. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1775 · Cited by 803
Aikawa, R., Komuro, I., Yamazaki, T., Zou, Y., Kudoh, S., Tanaka, M., Shiojima, I., Hiroi, Y., & Yazaki, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119709 · Cited by 687
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Hatley, M. E., Patrick, D. M., Garcia, M. R., Richardson, J. A., Bassel-Duby, R., van Rooij, E., & Olson, E. N. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.013 · Cited by 626
Redox signaling and the MAP kinase pathways
Torres, M., & Forman, H. J. (2003) · BioFactors · doi:10.1002/biof.5520170128 · Cited by 580
Dittmann, K., Mayer, C., Fehrenbacher, B., Schaller, M., Raju, U., Milas, L., Chen, D. J., Kehlbach, R., & Rodemann, H. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506591200 · Cited by 529
The roles of signaling pathways in bone repair and regeneration
Majidinia, M., Sadeghpour, A., & Yousefi, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26042 · Cited by 513
Self-citationInhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK
Allan, L. A., Morrice, N., Brady, S., Magee, G., Pathak, S., & Clarke, P. R. (2003) · Nature Cell Biology · doi:10.1038/ncb1005 · Cited by 474
The role of mitogen-activated protein (MAP) kinase in breast cancer
Santen, R. J., Song, R. X., McPherson, R., Kumar, R., Adam, L., Jeng, M.-H., & Yue, W. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00189-3 · Cited by 406
FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway
Gulbins, E., Bissonnette, R., Mahboubi, A., Martin, S., Nishloka, W., Brunner, T., Baier, G., Baler-Bltterlich, G., Byrd, C., Lang, F., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90142-6 · Cited by 399
Sahai, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.755 · Cited by 384
Friday, B. B., & Adjei, A. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4790 · Cited by 374
Reactive oxygen species signaling in vascular smooth muscle cells
CLEMPUS, R., & GRIENDLING, K. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.033 · Cited by 358
Molina, J. R., & Adjei, A. A. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31506-9 · Cited by 324
Therapeutic Strategies for Targeting Ras Proteins
Gysin, S., Salt, M., Young, A., & McCormick, F. (2011) · Genes & Cancer · doi:10.1177/1947601911412376 · Cited by 323
Mitogen-Activated Protein Kinases and Their Role in Radiation Response
Munshi, A., & Ramesh, R. (2013) · Genes & Cancer · doi:10.1177/1947601913485414 · Cited by 322
Signaling through the epidermal growth factor receptor during the development of malignancy
Grandis, J. R., & Sok, J. C. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.01.002 · Cited by 320
Reuter, C. W. M., Morgan, M. A., & Bergmann, L. (2000) · Blood · doi:10.1182/blood.v96.5.1655 · Cited by 300
Weyemi, U., Lagente-Chevallier, O., Boufraqech, M., Prenois, F., Courtin, F., Caillou, B., Talbot, M., Dardalhon, M., Al Ghuzlan, A., Bidart, J.-M., et al. (2012) · Oncogene · doi:10.1038/onc.2011.327 · Cited by 285
The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
Kumar, M. S., Hancock, D. C., Molina-Arcas, M., Steckel, M., East, P., Diefenbacher, M., Armenteros-Monterroso, E., Lassailly, F., Matthews, N., Nye, E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.059 · Cited by 265
The complexity of targeting EGFR signalling in cancer: From expression to turnover
Sebastian, S., Settleman, J., Reshkin, S. J., Azzariti, A., Bellizzi, A., & Paradiso, A. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.06.001 · Cited by 260
Small-molecule cyclin-dependent kinase modulators
Senderowicz, A. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206954 · Cited by 236
Role of Oxidative Stress in Stem, Cancer, and Cancer Stem Cells
Dayem, A. A., Choi, H.-Y., Kim, J.-H., & Cho, S.-G. (2010) · Cancers · doi:10.3390/cancers2020859 · Cited by 229
Toulany, M., Kasten-Pisula, U., Brammer, I., Wang, S., Chen, J., Dittmann, K., Baumann, M., Dikomey, E., & Rodemann, H. P. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2454 · Cited by 206
Weng, L.-P. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.6.605 · Cited by 199
Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy
Fan, M., & Chambers, T. C. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0214 · Cited by 198
Wang, D., Buchanan, F. G., Wang, H., Dey, S. K., & DuBois, R. N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3671 · Cited by 193
Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis
Lee, E.-R., Kim, J.-Y., Kang, Y.-J., Ahn, J.-Y., Kim, J.-H., Kim, B.-W., Choi, H.-Y., Jeong, M.-Y., & Cho, S.-G. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.06.006 · Cited by 190
Golding, S. E., Rosenberg, E., Neill, S., Dent, P., Povirk, L. F., & Valerie, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2371 · Cited by 189
Sun, D., Yu, F., Ma, Y., Zhao, R., Chen, X., Zhu, J., Zhang, C.-Y., Chen, J., & Zhang, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.367763 · Cited by 187
A Redox-triggered Ras-Effector Interaction
Deora, A. A., Win, T., Vanhaesebroeck, B., & Lander, H. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29923 · Cited by 180
Rowinsky, E. K. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104433 · Cited by 178
Dow, L. E., Elsum, I. A., King, C. L., Kinross, K. M., Richardson, H. E., & Humbert, P. O. (2008) · Oncogene · doi:10.1038/onc.2008.219 · Cited by 171
Park, J.-I., Lee, M.-G., Cho, K., Park, B.-J., Chae, K.-S., Byun, D.-S., Ryu, B.-K., Park, Y.-K., & Chi, S.-G. (2003) · Oncogene · doi:10.1038/sj.onc.1206478 · Cited by 168
PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling
Shrestha, Y., Schafer, E. J., Boehm, J. S., Thomas, S. R., He, F., Du, J., Wang, S., Barretina, J., Weir, B. A., Zhao, J. J., et al. (2012) · Oncogene · doi:10.1038/onc.2011.515 · Cited by 165
Melatonin: A pleiotropic molecule that modulates DNA damage response and repair pathways
Majidinia, M., Sadeghpour, A., Mehrzadi, S., Reiter, R. J., Khatami, N., & Yousefi, B. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12416 · Cited by 163
Self-citationGreenhough, A., Patsos, H. A., Williams, A. C., & Paraskeva, C. (2007) · International Journal of Cancer · doi:10.1002/ijc.22917 · Cited by 162
TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway
Meng, X., Cai, C., Wu, J., Cai, S., Ye, C., Chen, H., Yang, Z., Zeng, H., Shen, Q., & Zou, F. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.031 · Cited by 160
RAS signaling pathways, mutations and their role in colorectal cancer
Zenonos, K. (2013) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v5.i5.97 · Cited by 156
Toulany, M., Dittmann, K., Krüger, M., Baumann, M. A., & Rodemann, H. P. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.06.024 · Cited by 151
Targeting Checkpoint Kinase 1 in Cancer Therapeutics
Tse, A. N., Carvajal, R. D., & Schwartz, G. K. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2793 · Cited by 148
Reardon, D., Contessa, J., Mikkelsen, R., Valerie, K., Amir, C., Dent, P., & Schmidt-Ullrich, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202849 · Cited by 143
Donovan, J. C. H., Milic, A., & Slingerland, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106448200 · Cited by 137
Young, T. W., Mei, F. C., Yang, G. S., Thompson-Lanza, J. A., Liu, J., & Cheng, X. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0222 · Cited by 136
Horst, D. A., Chen, J., Morikawa, T., Ogino, S., Kirchner, T., & Shivdasani, R. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3222 · Cited by 133
Karimian, A., Majidinia, M., Baghi, H. B., & Yousefi, B. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.01.003 · Cited by 125
Self-citationEpidermal Growth Factor Signaling in Transformed Cells
Lindsey, S. C., & Langhans, S. A. (2014) · International review of cytology · doi:10.1016/bs.ircmb.2014.10.001 · Cited by 123
Kang, M. H., Oh, S. C., Lee, H. J., Kang, H. N., Kim, J. L., Kim, J. S., & Yoo, Y. A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.04.006 · Cited by 118
Shinohara, M., Shang, W.-H., Kubodera, M., Harada, S., Mitsushita, J., Kato, M., Miyazaki, H., Sumimoto, H., & Kamata, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609450200 · Cited by 108
Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development
Chung, E., & Kondo, M. (2010) · Immunologic Research · doi:10.1007/s12026-010-8187-5 · Cited by 107
Chen, T., Cho, R. W., Stork, P. A., & Weber, M. J. (1999) · PubMed · Cited by 106
Holbrook, N. J., & Ikeyama, S. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01169-3 · Cited by 103
Dai, Y., Chen, S., Pei, X., Almenara, J. A., Kramer, L. B., Venditti, C. A., Dent, P., & Grant, S. (2008) · Blood · doi:10.1182/blood-2008-05-159392 · Cited by 102
Friedmann, B. J., Caplin, M. E., Savic, B., Shah, T., Lord, C. J., Ashworth, A., Hartley, J. A., & Hochhauser, D. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0239 · Cited by 100
Diesch, J., Sanij, E., Gilan, O., Love, C. G., Tran, H., Fleming, N. I., Ellul, J., Marcia, A., Haviv, I., Pearson, R. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088950 · Cited by 98
MAPK Mediates RAS-induced Chromosome Instability
Saavedra, H. I., Fukasawa, K., Conn, C. W., & Stambrook, P. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38083 · Cited by 97
Shintani, S., Li, C., Mihara, M., Terakado, N., Yano, J., Nakashiro, K., & Hamakawa, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11437 · Cited by 95
Fukui, H., Zhang, X., Sun, C., Hara, K., Kikuchi, S., Yamasaki, T., Kondo, T., Tomita, T., Oshima, T., Watari, J., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.336 · Cited by 93
Knauf, J. A., Ouyang, B., Knudsen, E. S., Fukasawa, K., Babcock, G. F., & Fagin, J. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511690200 · Cited by 93
Protein Kinases as Drug Targets in Cancer
Arslan, M. A., Kütük, Ö., & Başağa, H. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906778742479 · Cited by 92
Marampon, F., Gravina, G. L., Rocco, A. D., Bonfili, P., Staso, M. D., Fardella, C., Polidoro, L., Ciccarelli, C., Festuccia, C., Popov, V. M., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0631 · Cited by 87
Misra, U. K., & Pizzo, S. V. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.2.10422 · Cited by 86
DNA damage response regulation by microRNAs as a therapeutic target in cancer
Majidinia, M., & Yousefi, B. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.09.003 · Cited by 84
Self-citationFriedmann, B. J., Caplin, M. E., Hartley, J. A., & Hochhauser, D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0586 · Cited by 79
Hütter, E., Unterluggauer, H., Überall, F., Schramek, H., & Jansen‐Dürr, P. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00136-5 · Cited by 68
Ras Induces Chromosome Instability and Abrogation of the DNA Damage Response
Abulaiti, A., Fikaris, A. J., Tsygankova, O. M., & Meinkoth, J. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2351 · Cited by 67
Emerging views of integrin signaling: Implications for prostate cancer
Slack‐Davis, J. K., & Parsons, J. T. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10665 · Cited by 66
Wei, F., Yan, J. J., & Tang, D. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711798194388 · Cited by 63
Kimball, S. R., Abbas, A., & Jefferson, L. S. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00539.x · Cited by 62
RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance
Ray, H., Roméo, Y., Lavoie, G., Déléris, P., Tcherkezian, J., Galan, J. A., & Roux, P. P. (2012) · Oncogene · doi:10.1038/onc.2012.472 · Cited by 51
Inaba, H., Kuboniwa, M., Sugita, H., Lamont, R. J., & Amano, A. (2012) · Infection and Immunity · doi:10.1128/iai.00258-12 · Cited by 46
Fibroblast Growth Factor-10 Attenuates H2O2-Induced Alveolar Epithelial Cell DNA Damage
Upadhyay, D., Bundesmann, M. M., Panduri, V., Correa-Meyer, E., & Kamp, D. W. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0064oc · Cited by 45
Mei, F. C., Young, T. W., Liu, J., & Cheng, X. (2005) · The FASEB Journal · doi:10.1096/fj.05-4586fje · Cited by 41
p53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints
Agapova, L. S., Ivanov, A., Sablina, A. A., Kopnin, P., Oi, S., Chumakov, P. M., & Kopnin, B. P. (1999) · Oncogene · doi:10.1038/sj.onc.1202386 · Cited by 40
Chen, Y. (2011) · Oncology Reports · doi:10.3892/or.2011.1507 · Cited by 38
Zhong, J., Zhao, M., Luo, Q., Ma, Y., Liu, J., Wang, J., Yang, M., Yuan, X., Sang, J., & Huang, C. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1418-4 · Cited by 37
Membrane receptor signaling and control of DNA repair after exposure to ionizing radiation
Toulany, M., & Rodemann, H. P. (2010) · Nuklearmedizin - NuclearMedicine · doi:10.1055/s-0038-1626525 · Cited by 34
Weidhaas, J. B., Eisenmann, D. M., Holub, J. M., & Nallur, S. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2182 · Cited by 29
Fighting cancer by disrupting C-terminal methylation of signaling proteins
Clarke, S. G., & Tamanoi, F. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421059 · Cited by 28
Nitrative and oxidative DNA damage caused by K-ras mutation in mice
Ohnishi, S., Saito, H., 昇, 鈴., Ma, N., Hiraku, Y., Murata, M., & Kawanishi, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.076 · Cited by 7
Cited by
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Aggarwal, V., Tuli, H., Varol, A., Thakral, F., Yerer, M., Sak, K., Varol, M., Jain, A., Khan, M., & Sethi, G. (2019) · Biomolecules · doi:10.3390/biom9110735 · Cited by 1,221
Oral squamous cell carcinomas: state of the field and emerging directions
Tan, Y., Wang, Z., Xu, M., Li, B., Huang, Z., Qin, S., Nice, E. C., Tang, J., & Huang, C. (2023) · International Journal of Oral Science · doi:10.1038/s41368-023-00249-w · Cited by 831
The anti-cancer effect of quercetin: molecular implications in cancer metabolism
Reyes-Farias, M., & Carrasco-Pozo, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133177 · Cited by 689
“These transcription factor molecules, AP-1 and NF-κB, are involved in the neoplastic transformation and development of cancer and are regulated by upstream kinases, including MAPKs signaling pathways [81,82].”
BackgroundSadiq, I. Z. (2023) · Current Molecular Medicine · doi:10.2174/1566524022666211222161637 · Cited by 263
The Signaling Pathways Regulating NLRP3 Inflammasome Activation
Chen, M.-Y., Ye, X.-J., He, X.-H., & Ouyang, D.-Y. (2021) · Inflammation · doi:10.1007/s10753-021-01439-6 · Cited by 154
Metadata
- Authors
- Rezatabar, S., Karimian, A., Rameshknia, V., Parsian, H., Majidinia, M., Kopi, T. A., Bishayee, A., Sadeghinia, A., Yousefi, M., Monirialamdari, M., & Yousefi, B.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2019-02-27
- Volume
- 234
- Issue
- 9
- Pages
- 14951-14965
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2915767933
- Cited by
- 340
- References
- 93
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.